CARVYKTI

Indicated For

multiple myeloma

About This Medication

# MyCARVYKTI Patient Support Program Patient Guide: How to Get CARVYKTI (ciltacabtagene autoleucel) at Low or No Cost The **MyCARVYKTI Patient Support Program**, sponsored by Janssen Biotech, Inc. and Legend Biotech, helps eligible patients prescribed **CARVYKTI (ciltacabtagene autoleucel)** cover travel-related expenses like transportation, lodging, meals, and out-of-pocket costs during treatment at an Activated Treatment Center.[1][2] This guide explains eligibility, the treatment, application steps, and more to make the process smoother for you and your care partner. ## About CARVYKTI **CARVYKTI** is a personalized CAR-T cell therapy for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.[2] It involves collecting your T cells (a type of white blood cell) through leukapheresis, genetically modifying them in a lab to target cancer cells, and infusing them back into your body after low-dose chemotherapy.[2][5] The process happens at a specialized **Activated Treatment Center** (ATC), and you'll need to stay nearby for monitoring—10 days inpatient post-infusion and 4 weeks total close by.[2] The full timeline includes: - **Step 1: Cell collection** (~3-6 hours, may repeat).[5] - **Step 2: Manufacturing** (~4-5 weeks).[2][5] - **Step 3: Bridging therapy and pre-infusion chemo** (while waiting).[2] - **Step 4: One-time infusion** (3-6 hours), followed by monitoring.[2][5] Your primary oncologist coordinates with an ATC for consultation and eligibility.[2] CARVYKTI isn't a traditional pill or infusion you pick up—it's custom-made, so support focuses on getting you to and from treatment safely.[1] ## Who Qualifies for MyCARVYKTI? You may qualify if: - You've been **prescribed CARVYKTI** by your doctor.[1][2] - You live in the **United States or its territories**.[1] - You meet **distance criteria** (typically far from an ATC, as travel support is key).[1][2] - You satisfy **income eligibility** and other financial requirements.[1][4] The program supports **patients and care partners** for leukapheresis, infusion, and bridging therapy at an ATC.[1][2] Care partners help with side effect monitoring, appointments, transport, communication, home tasks, and emotional support.[2] ## Income Eligibility Breakdown Specific income thresholds (e.g., Federal Poverty Level percentages) aren't publicly detailed online—eligibility is determined case-by-case based on financial need, distance, and other factors.[1][4] Contact the program for a personalized assessment. Here's a general overview based on similar programs (note: confirm with MyCARVYKTI for exacts): | Household Size | Estimated Max Income (e.g., 400-500% FPL)* | Notes | |---------------|--------------------------------------------|-------| | Individual | ~$60,000-$75,000 | Varies; income + distance apply[1] | | Couple | ~$80,000-$100,000 | Household income assessed[4] | | Family of 3 | ~$100,000-$125,000 | Includes care partners[1] | | Family of 4+ | ~$120,000+ | Call for details[1] | *Estimates for 2026 FPL; actuals depend on program rules. No fixed %FPL listed—must meet 'financial and other eligibility.'[1][4] ## Insurance Requirements MyCARVYKTI focuses on **travel and out-of-pocket travel costs**, not the drug cost itself.[1][2][6] Your healthcare team and ATC handle **prior authorization** with your insurer.[1] Ask your provider: - What documents speed up approval? - Any extra info needed from you or your doctor?[1] The program works alongside insurance—eligible patients get travel help regardless of coverage type (commercial, Medicare, etc.), as long as prescribed.[2][6] No specific insurance exclusions noted, but confirm coverage for CARVYKTI treatment separately.[1] ## Step-by-Step Application Process 1. **Get Prescribed**: Discuss with your oncologist; they'll refer you to an ATC for consultation.[2] 2. **Call MyCARVYKTI**: Dial **1-800-559-7875** (option 1), Mon-Fri 8 AM-8 PM ET, as soon as prescribed.[1][2][3] 3. **Speak to a Specialist**: They'll guide enrollment, check eligibility (income, distance, prescription).[1][3][4] 4. **Provide Info**: Share household income, address (for distance), prescription details. No standard document list published—specialists advise.[1] 5. **Approval**: If eligible, arrangements start (e.g., travel bookings).[2] 6. **Travel Support**: Program handles transport (mileage, bus/rail/air), lodging near ATC, meal per diem, OOP expenses for approved trips.[1][2] Support is 24/7 via travel provider once enrolled.[1] ## Timeline and Delivery - **Enrollment**: Immediate call; eligibility check same day or soon after.[1] - **Treatment Timeline**: 6-11 weeks total (collection to infusion).[2][5] Manufacturing: 4-5 weeks.[2] - **Support Delivery**: Booked per trip (leukapheresis, infusion, bridging). Ground/air transport to/from ATC; lodging arranged; meal reimbursements.[1][2] - **Post-Treatment**: Plan 4 weeks near ATC; ongoing oncologist follow-up.[2] Processing time varies—start early to avoid delays.[9] ## Alternatives if Denied - **Reapply/Appeal**: Discuss denial reasons (e.g., income/distance) with specialists; resubmit if circumstances change.[1] - **Other Resources**: Check Medicine Assistance Tool or NeedyMeds for copay/drug aid.[6][7] - **Hospital Funds**: Ask ATC about charity care or travel grants.[2] - **Crowdfunding**: Platforms like HealthTree for myeloma support.[4] - **No Biosimilars**: CARVYKTI is unique; alternatives are other myeloma therapies via your doctor.[ ] ## Disclaimer This guide is for informational purposes based on available resources as of 2026.[1][2] Eligibility, benefits, and rules can change—**always contact MyCARVYKTI at 1-800-559-7875 for latest details**. Not a substitute for medical/insurance advice. Consult your doctor for treatment suitability. Program doesn't guarantee drug coverage, only travel support for eligibles.[1][6] Word count: ~950.

Program information last verified: March 25, 2026